Neil Stahl Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity
Neil Stahl is EVP Research and Development of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 48,829 shares of REGN, which is worth approximately $34 Million. The most recent transaction as insider was on Dec 11, 2021, when has been sold 753 shares (Common Stock) at a price of $664.34 per share, resulting in proceeds of $500,248. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
48.8K
1.55%
3M change
18.69%
12M change
Total Value Held
$34 Million
NEIL STAHL Transaction History
NS
Neil Stahl
EVP Research and Development
Tarrytown, NY